1995
DOI: 10.1016/s0167-7799(00)88912-x
|View full text |Cite
|
Sign up to set email alerts
|

Biomedical and biotechnological applications of PEG- and PM-modified proteins

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
101
0
2

Year Published

1997
1997
2015
2015

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 215 publications
(105 citation statements)
references
References 50 publications
2
101
0
2
Order By: Relevance
“…The purpose of these studies was to enhance the merits and improve the defects of proteins and to apply such conjugates for use in such fields as medical, pharmaceutical, engineering and agricultural sciences. Representative protein conjugates with synthetic polymers include the conjugates of proteins and polyethylene glycol (Inada et al, 1995;Veronese, 2001) and immobilized enzymes (Taylor, 1991;Liang et al, 2000). On the other hand, many studies to improve the functions of proteins by conjugation with various saccharides were also conducted: alkylation (Nieto & Palacian, 1983;Sen et al, 1981) esterification , amidation , deamidation (Matsudomi et al, 1985;Wu et al, 1976), lipophilization (Akita & Nakai, 1990a;1990b), covalent attachment of gluconic acid (Kitabatake et al, 1985), cross-linking with transglutaminase (Nio et al, 1985;Motoki et al, 1987) and so on.…”
Section: Introduction: What Is Neoglycoprotein ?mentioning
confidence: 99%
“…The purpose of these studies was to enhance the merits and improve the defects of proteins and to apply such conjugates for use in such fields as medical, pharmaceutical, engineering and agricultural sciences. Representative protein conjugates with synthetic polymers include the conjugates of proteins and polyethylene glycol (Inada et al, 1995;Veronese, 2001) and immobilized enzymes (Taylor, 1991;Liang et al, 2000). On the other hand, many studies to improve the functions of proteins by conjugation with various saccharides were also conducted: alkylation (Nieto & Palacian, 1983;Sen et al, 1981) esterification , amidation , deamidation (Matsudomi et al, 1985;Wu et al, 1976), lipophilization (Akita & Nakai, 1990a;1990b), covalent attachment of gluconic acid (Kitabatake et al, 1985), cross-linking with transglutaminase (Nio et al, 1985;Motoki et al, 1987) and so on.…”
Section: Introduction: What Is Neoglycoprotein ?mentioning
confidence: 99%
“…PEG-asparaginase was found to be a useful alternative in patients with prior clinical hypersensitivity to native E. coli asparaginase. PEG-asparaginase reduces the immunogenicity of the protein, increases its stability in plasma and is suitable for use in heavily pretreated patients [60]. The recommended dose of pegaspargase is 2.5 IU/m 2 Intramuscularly (IM) or Intravenously (IV), and should be administered for every 14 days.…”
Section: Applications Of Microbial Amidases Therapeutic Applicationsmentioning
confidence: 99%
“…При использовании модифицированных ПЭГ L-аспарагиназ (ПЭГ-АСП) возрастает продолжительность их циркуляции в крови и биостабильность, вероятно, связанные с повышением устойчивости к протеолизу; снижается связывание с антителами и поглощение ретикулоэндотелиальной системой, а также способность вызывать аллергические реакции [75,76]. Всё это повышает терапевтическую эффективность и уменьшает вероятность побочных эффектов при длительном применении L-аспарагиназы.…”
Section: пегилированиеunclassified